What are the key factors influencing the ROI? What are the latest advancements in imaging technology? How is the use of robotics opening new avenues of growth? How is medical tourism driving investments? How are stakeholders reducing operational costs?
What are the regulatory and reimbursement changes? What are the strategic priorities? How are technologies like AI and cloud-based platforms creating new growth opportunities? What efforts are being taken by the leading participants to gain a competitive edge?
What are the emerging business models? What are the new types of robotic surgeries? What factors are accelerating the demand for bio-surveillance devices? How is digital data delivering value to patients and providers?
The Sheconomy impacts almost every economic sector because a more significant proportion of highly educated women are joining the global workforce every year. With the increase in spending power, women are propelling economic activity from both ends—accelerating growth as a workforce and featuring as promising retail consumers. However, this female-powered economy is more than a mega trend for leveraging the economy. It is a massive force that addresses the inequalities women have faced at home, in society, and in their workplaces for generations.
Schedule a dialog or email us at myfrost@frost.com to connect with an industry expert at no charge. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
Which initiatives help pharmaceutical companies remain competitive?
Read more Request Info
What new technologies are powering the future of this sector?
Read more Request Info
What are the key regulatory policies adopted by the government?
Read more Request Info
How are advanced solutions facilitating domestic manufacturing?
Read more Request Info
Explore the computer vision technologies transforming this space
Read more Request Info
How is technology transfer paving the way for patient-centric models?
Read more Request Info
Which innovative opportunities for vendors are driven by cybersecurity?
Read more Request Info
What are the intelligent applications focusing on virtual hybrid trials?
Read more Request InfoThe Sheconomy impacts almost every economic sector because a more significant proportion of highly educated women are joining the global workforce every year. With the increase in spending power, women are propelling economic activity from both ends—accelerating the firm’s growth as a workforce and featuring as promising retail consumers. However, this female-powered economy is more than a mega-trend for leveraging the economy.
Read more
Based on its recent analysis of the clinical decision support systems (CDSS) industry, Frost & Sullivan recognizes EBSCO Information Services (EBSCO) and specifically its Clinical Decisions products with the 2022 North America Product Leadership Award for delivering forward-thinking products that support evidence-based clinical decision-making and patient engagement.
Read more
The global vaccine market is growing rapidly, thanks to the huge investments and competition during the COVID-19 pandemic, but there are still many challenges to address. These issues include tackling the diseases that lack an effective vaccine and developing new technologies and approaches to address a future pandemic.
Read more
The increased number of patients using digital health tools, such as telehealth and other enterprise IT solutions, empowered consumers to manage their health and accelerated global digital health market growth, according to Frost & Sullivan’s recent analysis, Global Digital Health Outlook. These tools will help ensure patient engagement and avoid staff burnout. Under the aspirational scenario, the global market for digital health will likely garner $205.13 billion in revenue by the end of 2022 from $178.37 billion in 2021.
Frost & Sullivan’s recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value chain. Data, the decentralization of clinical trials, supply-chain resilience, digital therapeutics, and manufacturing automation are the key areas driving digitalization.
New technologies, sequencing methods, novel software algorithms, and multi-omic approaches empower patients to take more active control of their health outcomes and offer them personalized medicine. The forces of change and partnerships are building the foundation to better engage with patients and approach new demands, according to Frost & Sullivan’s recent analysis, Next-generation Diagnostics Outlook 2022.
Read more
